Study of pitavastatin 1 mg vs. pravastatin 10 mg, pitavastatin 2 mg vs. pravastatin 20 mg and pitavastatin 4 mg vs. pravastatin 40 mg (following up-titration) in elderly patients with primary hypercholesterolemia or combined dyslipidemia.

Trial Profile

Study of pitavastatin 1 mg vs. pravastatin 10 mg, pitavastatin 2 mg vs. pravastatin 20 mg and pitavastatin 4 mg vs. pravastatin 40 mg (following up-titration) in elderly patients with primary hypercholesterolemia or combined dyslipidemia.

Completed
Phase of Trial: Phase III

Latest Information Update: 09 Nov 2012

At a glance

  • Drugs Pitavastatin (Primary) ; Pravastatin (Primary)
  • Indications Dyslipidaemias; Hypercholesterolaemia
  • Focus Registrational; Therapeutic Use
  • Sponsors Kowa
  • Most Recent Events

    • 01 Sep 2010 Results presented at the ESC Congress 2010: Annual Congress of the European Society of Cardiology.
    • 29 Aug 2010 Extension study results presented at the Annual Congress of the European Society of Cardiology (ESC) 2010 meeting.
    • 29 Aug 2010 Results presented at the Annual Congress of the European Society of Cardiology (ESC) 2010 meeting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top